loading page

Lymphocyte subsets in 32 patients with multisystem inflammatory syndrome in children (MIS-C)
  • +4
  • Magdalena Okarska-Napierała,
  • Joanna Mańdziuk,
  • Wojciech Feleszko,
  • Anna Stelmaszczyk-Emmel,
  • Mariusz Panczyk,
  • Urszula Demkow,
  • Ernest Kuchar
Magdalena Okarska-Napierała
Medical University of Warsaw

Corresponding Author:magda.okarska@gmail.com

Author Profile
Joanna Mańdziuk
Medical University of Warsaw
Author Profile
Wojciech Feleszko
Medical University of Warsaw
Author Profile
Anna Stelmaszczyk-Emmel
Medical University of Warsaw
Author Profile
Mariusz Panczyk
Medical University of Warsaw
Author Profile
Urszula Demkow
Medical University of Warsaw
Author Profile
Ernest Kuchar
Medical University of Warsaw
Author Profile

Abstract

BACKGROUND: Lymphopenia is a hallmark of multisystem inflammatory syndrome in children (MIS-C). We aimed to characterize lymphocyte subsets’ shifts and their correlations with other severity markers of MIS-C. METHODS: In this prospective cross-sectional study, we performed peripheral lymphocyte phenotyping in 32 patients with MIS-C. We analyzed lymphocyte subsets at three time-points of the disease: the acute (A), convalescent (B), and recovery (C) phases. Based on age-normalized lymphocyte counts, we distinguished two groups of patients: “the mild” and “the severe”. In addition, we examined differences between these groups regarding other severity markers. RESULTS: In phase A, 84% of children had lymphopenia. Decreased absolute counts of CD3, CD4, and CD8 cells were observed in, respectively, 88%, 72%, and 84% of patients. The natural killer cells were decreased in 63% and CD19 in 59% of children. “The severe” group had significantly higher procalcitonin and troponin I levels and lower platelets and albumin. Moreover, “the severe” group had hypotension more frequently (73% vs. 20%, p=0.008). In phase B, all lymphocyte counts increased, and 32% of children had lymphocytosis. The increase of CD3, CD4, and CD8 counts correlated with some laboratory severity markers (hemoglobin, procalcitonin, D-dimer, lactate dehydrogenase, N-terminal prohormone of brain natriuretic peptide, albumin), but not with steroid use. In phase C, most children had normal lymphocyte counts. CONCLUSIONS: Substantial shifts in lymphocyte counts during MIS-C apply most to T lymphocytes and correlate with the disease severity markers, particularly hypotension prevalence. A proportion of children with MIS-C develops transient lymphocytosis during convalescence.
27 May 2021Submitted to Pediatric Allergy and Immunology
31 May 2021Reviewer(s) Assigned
17 Jun 2021Review(s) Completed, Editorial Evaluation Pending
23 Jun 2021Editorial Decision: Revise Minor
15 Jul 20211st Revision Received
16 Jul 2021Review(s) Completed, Editorial Evaluation Pending
22 Jul 2021Editorial Decision: Accept